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Infectious Episodes in Severely Granulocytopenic Patients
Sum m ary: In a prospective study, 40 episodes o f granulocyto­
penia (granulocytes <  500/mm3) in 34 patients were analyzed. 
During 52.5°/o o f these episodes there was proven infection; 
these infections were present for only 24.4% of the 1,435 
granulocytopenic days. The risk of infection and mortality  
were closely linked with extreme granulocytopenia (granulo­
cytes <  100/mm3). Of the episodes with severe granulocyto­
penia (granulocytes 100—500/mm3) only a small number were 
associated with infections, and mortality was virtually absent 
in this category. These results implicate a restricted use of 
supportive measures (e. g. granulocyte transfusions) especially  
when granulocyte counts are higher than 100/mm3.
Zusam m enfassung: In fek tiö se  Episoden bei schw er granulo- 
zytopenischen Patienten. In einer prospektiven Untersuchung 
wurden 40 granulozytopenischen Episoden (Granulozyten  
<  500/mm3) bei 34 Patienten analysiert. Während 52,5%  die­
ser Episoden wurden Infektionen nachgewiesen. D iese Infek­
tionen waren nur während 24.2% von den 1435 granulozyto­
penischen Tagen vorhanden. Das Infektions- und M ortalitäts- 
risiko stand in enger Beziehung zu extremer Granulozytopenie 
(Granulozyten <  100/mm3), Nur eine geringe A nzahl der Epi­
soden mit schwerer Granulozytopenie (Granulozyten 100 bis 
500/mm3) ging mit Infektionen einher, und Todesfälle kamen 
in dieser Gruppe nahezu nicht vor. Diese Resultate sprechen 
für eine beschränkte Anwendung von unterstützenden M aß­
nahmen (z. B. Granulozytentransfusionen), insbesondere wenn 
die Granulozytenzahl über 100/mm3 liegt.
Introduction
Bacterial infections constitu te  a serious p ro b lem  in  p a ­
tients w ith g ranulocytopenia. Since 1966 a lim ited  nu m b er 
of studies has show n the gradual bu t strong  increase  in  
the incidence of infections and m ortality  w hen  g ran u lo ­
cytes decrease fro m  l,0 0 0 /m m s to  zero/m m s (1—3).
M any authors advocate  aggressive therapeu tic  an d  p re ­
ventive m easures fo r  granulocytopenic pa tien ts : e. g. 
p rom p t broad-spectrum  therapy  w ith two, th ree , o r m ore  
antibiotics as soon as fever develops (4, 5); an tib io tic  p ro ­
phylaxis on a large scale (6); supplem entary  trea tm en t 
w ith granulocyte transfusions, either therapeu tica lly  (7, 8) 
or prophylactically  (9). O ver the past five years o u r po licy  
fo r g ranulocytopenic patients has been less aggressive: no 
systemic antibiotics are  given un til bacte rial in fec tio n  is 
seriously suspected o r p roven  (thus: fever alone is n o t 
taken  as an  ind ica tion  to  start antib io tic th e rap y ) and  
granulocyte transfusions a re  only given to  patien ts w ith  
absolute agranulocytosis and  a proven  b ac te ria l in fec tion  
th a t does no t respond  to  appropriate  an tib io tic  th e rap y  
(10). W e favour such a less aggressive an tib io tic  th erap y  
because this approach  gives m ore  tim e and  possibilities 
fo r m icrobiological investigations and o th e r d iagnostic 
procedures, which m eans th a t bacterial in fec tion  m ay  be
excluded  o r m ore  exactly  d iagnosed , the latter perm itting  
be tte r-ad ju sted  an tib io tic  th e rap y . The restricted use of 
an tib io tics also leads to  less em ergence of resistant m icro­
organ ism s in  the  p a rtic u la r p a tie n t and in the hospital as 
w ell as to  few er side effec ts an d  costs.
R estric ted  use o f  g ran u lo cy te  transfusion reduces costs, 
dono r p rob lem s, and  sen sitiza tion  and other side effects. 
H ow ever, w e questioned  w h e th e r our less aggressive ap ­
proach  is d e trim en ta l fo r  granulocy topenic  patients in  our 
hosp ita l. T he  questions w e asked  ourselves w ere: (a) To 
w hat deg ree  a re  g ran u lo cy to p en ia  and infection related  
in o u r patien ts , i. e., d u ring  w h a t percentage of g ranulo­
cy topenic  days is in fec tio n  p resen t?  (b) How m any p a ­
tients d ie  u n d e r  ou r th e rap eu tic  approach? On this basis, 




A ll patients (both in- and out-patients) in the Departments of 
H aem atology and General Internal Medicine with granulocyte 
counts below  500/m m 3 for at least three days were included 
in the study; no other selection was applied. The period of the 
study was the first six m onths o f  1976. Cell counts were per­
formed at least three tim es a week.
C lassification
In fec tio u s  status: Proven bacterial and fungal infections (i. e., 
proven by biopsy or culture) were classified as either major 
(severe) infections or m inor infections. Septicaemia or organ 
invasion (e. g. pneum onia, perirectal abscess, meningitis, endo­
carditis, arthritis, and osteom yelitis) were considered major 
infections; stomatitis, pharyngitis, skin abscess, and sinusitis 
were classified as m inor infections. Episodes during which 
there w ere signs that could be attributed to infection (e. g. 
fever alone) but proof o f infection could not be obtained were 
classified as doubtful infection. The duration of an infectious 
episode was defined as the number of days between the first 
day on which sym ptom s and signs attributable to infection 
appeared and the first day on which all signs of infections 
were gone.
G ranulocytopenia: An episode of granulocytopenia was taken 
as the number o f  days during which a patient had less than 
500 granulocytes/m m 3. A  division according to the severity of 
the granulocytopenia was applied for the analysis of the re-
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suits, i. e., severe  granulocytopenia (100—500 granulocytes/ 
mma) and extrem e  granulocytopenia (less than 100 granulo­
cytes/m m 3).
H aem atological status: A  patient was considered haemato- 
logically refractory when the short-term prognosis o f  the 
underlying disease was very poor due, for instance, to high  
numbers o f circulating leukaemic cells unaffected by various 
chemotherapeutic agents, no recovery of the bone marrow in 
leukaemia, and leukaemic infiltrates at other sites resistant to 
chemotherapy.
M anagem ent o f the Patients
N ursing: Admitted patients were nursed in reversed isolation  
in a conventional isolation room in a normal hospital ward. 
Patients selected for bone marrow transplantation were nursed 
in ultraclean rooms or down-flow isolators in the Isolation  
Pavillion and received partial antibiotic decontamination 
(PAD) (11).
M icrobio logy and an tib io tic  treatm ent: Bacterial examination 
and antibiotic treatment were performed as described e lse­
where (10). In short: A  bacteriological inventory was carried 
out on admission and repeated once a week. The patients were 
examined and treated for chronic asymptomatic infections 
(e. g, dental granuloma) and for carrier state of S ta p h ylo ­
coccus aureus  and C andida  spp. N o  systemic antibiotic treat­
ment was instituted until bacterial infection was seriously 
suspected or proven. Fever alone was not considered an indi­
cation for antibiotic treatment. The choice o f the antibiotics 
was governed by the site o f infection and the suspected causa­
tive micro-organism (based on gram-stained microscopical 
preparations, results o f previous cultures, etc.). Initial therapy 
alm ost always consisted o f a combination of two antibiotics 
given intravenously. When P seudom onas infection was sus­
pected, the initial therapy consisted of carbenicillin and genta- 
micin; when K lebsie lla  or Escherichia coli were suspected, 
cephalothin and gentamicin were the initial therapy; cloxacil- 
lin and gentamicin were given in cases o f suspected staphylo­
coccal infection. W henever possible, antibiotic therapy was 
adjusted on the basis o f the results of bacteriological inves­
tigations.
Transfusions: Granulocyte transfusions were only given to 
patients with agranulocytosis and proven serious infections 
not responding to proper antibiotic therapy within 24 hours. 
Granulocytes were harvested by collection of buffy coats from  
fresh units o f heparin blood from random unpaid blood-bank  
donors. N o  prem edication or sedimenting agents were used. 
A ll donors were negative for hepatitis-associated surface anti­
gen and syphilis serology. Daily, 3 . 5 - 6  X 109 granulocytes 
were transfused. The leucocyte suspensions were irradiated
with 1,500 rads to prevent accidental engraftment and possible 
subsequent graft versus host disease (12). Extremely leucocyte- 
poor red-cell suspensions for transfusion were prepared by the 
use of a cotton wool filter* (13). Platelet concentrates were 
made leucocyte-poor by an extra centrifugation step (14).
Statistical Analysis
Statistical comparisons were performed with the -/2 test with 
the Yates correction (15).
Results
T hirty-four patients (20 m ales and  14 fem ales) w ere  stud­
ied. T he diagnoses in these cases are  given in T ab le  1. The 
average age was 41.8 years (range 13—71 years); 13 pa­
tients were over 50 years old. In  this group th e re  were
Table 1: Underlying diagnoses in the present study.
Diagnosis N o. of 
patients
N o . of 
episodes
Acute myelocytic leukaemia 14 16
Acute monocytic leukaemia 3 4
Acute lymphocytic leukaemia 3 4
Acute undifferentiated leukaemia 2 2
Chronic myelocytic leukaemia 




Unclassified myeloproliferative disease 2 2




rejection of renal transplant 1 1
Disseminated thyroid carcinoma 1 1
34 40
40 episodes of granulocytopenia to talling  1,435 days, 
giving an average of 35.8 days p e r  episode. F igure 1 shows 
the num ber and percentage o f to ta l episodes (a) a n d  days 
(b) associated with m ajor, m inor, and  doubtfu l infections. 
The occurrence and dura tion  of proven  infections in  each 
granulocytopenic episode and the d u ra tion  o f th a t episode
* Produced by the Central Laboratory of the Netherlands* 
Red Cross Blood Transfusion Service, Amsterdam









Figure 1: N u m b e r  o f  episodes (a) and days (b) o f granulocytopenia  and proportion o f infections. M  =  m ajor in fe c tio n ,  
m  =  m inor in fection , d  =  d o u b tfu l in fection .
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is given in  F igure 2 a. T he  sam e data  fo r  episodes o f ex­
treme granulocytopenia only are  given in  F ig u re  2 b.
The incidence of in fection  during severe an d  ex trem e 
granulocytopenia is given in T able 2. D u rin g  severely  
granulocytopenic episodes the incidence (4 o u t o f 15 epi­
sodes) is significantly low er (yj2: 4,87, p  <  0.027) th a n  
during extrem ely granulocytopenic episodes). If only m a ­
jor infections are considered, this d ifference is significant 
at p <  0.010 (1 in  15 vs 13 in  25; 6.59).







( <  100/m m 3)
Proven infection 4 17
major 1 13
minor 3 4
No/doubtful infection 11 8
Total 15 25
The nature  o f the infections in  the various episodes and  
the m ortality  involved is given in  T ab le  3. O f th e  34 p a ­
tients in  this series, 12 died during an  episode of g ranu lo -
D u ra t io n  o f in fe c tio n  D uration o f g ran ulocytopen ia )
Figure 2: Patterns o f  dura tion  o f proven infection and of 
granulocytopenia  grouped  according to length of the  granulo­
cytopen ic  period . O ne h o rizon ta l bar represents one episode, 
a: all episodes o f granulocytopenia  ( <  5 0 0 /m m 3); 
b: episodes o f ex trem e  granulocytopenia  (<  100/m m s).
▼ granulocyte  transfusions
* two separate in fec tio n s  during one period o f  granulo­
cytopenia
P A D  partial a n tib io tic  decontam ination  
t  died  during  granulocytopenia
cytopenia . T ab le  4 show s th e  m ortality  according to cause 
of d e a th  and  severity  o f th e  granulocytopenia. O ne o u t of 
15 episodes o f severe granu locy topen ia  and 11 out o f  25 
episodes o f  ex trem e g ranulocy topenia  ended in death. 
T his d ifference  is sign ifican t ( :  4.57, p <  0.032). The 
on ly  fa ta lity  in  th e  severely  granulocytopenic episodes 
w as caused by  m y o card ia l infarction , whereas eight out 
of 11 deaths d u rin g  ex trem e  granulocytopenia w ere due 
to  an  in fection . T h e  o th e r  two causes of death in  this last 
g ro u p  w ere  leu k aem ic  p u lm o n a ry  infiltration and  adrenal 
haem o rrh ag e , and  in  one p a tien t the cause of death  was 
unknow n . T hese d a ta  lin k  m orta lity  due to in fection  and 
ex trem e g ran u lo cy to p en ia  closely ( -jJ: 4.17, p  <  0.041). 
O f th e  eigh t p a tien ts  w h o  died due to  infection u nder 
ex trem e g ranu locy topen ia , seven were classified as hae- 
m ato log ically  re frac to ry . T h e  only patient in  this group 
w ho died  in spite o f  a good  short-term  prognosis was a 
62 year-o ld  m a n  su ffe ring  fro m  a pulm onary  infiltrate 
w ith o u t sep ticaem ia d u rin g  cytostatic treatm ent for acute 
lym phocy tic  leukaem ia .
A ll in fections w ere  tre a ted  w ith systemic antibiotics and 
fo r  five in fections in  five p a tien ts  granulocyte transfusions 
w ere  added  to  th e  reg im en  on th e  indications m entioned 
above. T w o o f  these  five patien ts were classified as hae-
Infection  7 (1979) N r. 4 1 7 3
J. fV. M .  van der M eer  e t al.: Infectious episodes in granulocytopenic patients
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M ajor infection  
Septicemia due to a 
gram-negative species* 5 3
Septicemia due to a 
gram-positive species* 2 0
Septicemia due to both, gram- 
positive and gram-negative species* 1 0
Septicemia & pneumonia 2 2
Pneum onia (blood cultures negative) 1 1
Perirectal abscess 2 1
Disseminated fungus infection , 1 1
Total 14 8




Leg ulcer 1 0
Total 7 1
* N o  signs of pneumonia.
Table 4: M o rta lity  during granulocytopenic episodes.
Severe Extreme
granulocytopenia granulocytopenia 
(100-500/m m 3) «  100/mm3)
Death 1 11
due to infection 0 8
due to other causes 1 3
Survival 14 14
Total 15 25
m atologically  re frac to ry  and  died due  to  infection despite 
trea tm en t; the o th e r th ree  survived.
O f the 34 p a tien ts  w ith  g ranulocytopenia, th ree  w ere 
nu rsed  in  stric t iso la tion  and  received PA D  during four 
extrem ely  granu locy topen ic  episodes. In  three o f  these 
episodes no in fec tion  was seen; in  the fou rth  episode, 
anaerob ic  sep ticaem ia developed a fte r sigm oidoscopy in 
a  23 year-o ld  m ale  w ith  aplastic anaem ia. Since th e  tre a t­
m en t given during  these episodes differed, these cases 
w ere excluded  in  a  recalcu la tion  o f th e  incidence o f  in ­
fec tion  in  severe and  ex trem e g ranulocy topenia  (Table 5).
Table 5: Incidence o f  in fection  during granulocytopenic epi­








Proven infection 4 16
N o/doubtful infection 11 5
Total 15 21
T h e  difference betw een the severely and extrem ely gra­
nulocytopenic episodes is now  significant at p  <  0.005 
(z *: 6.80).
Discussion
Infection is the m ain hazard  in  th e  neutropenic p a tien t (1). 
T his is reflected in ou r study, w here the m ajo rity  of the 
granulocytopenic episodes w ere associated w ith infection. 
W e found the risk of infection  greatly  increased in  pa­
tients in whom the granulocy te  count fell below 100/m m3, 
an d  all deaths due to  infection occurred  in re la tion  to 
these extremely granulocytopenic episodes. Of th e  epi­
sodes with severe g ranulocytopenia  (100—500 granulo­
cytes/m m3), only a sm all num ber w ere associated with 
infections and m ortality  was v irtually  absent in th is cate­
gory. The need fo r a m ore aggressive antib io tic therapy 
and  for such trea tm en t as p rophylactic  antib io tics and 
prophylactic granulocyte transfusions is th e re fo re  ques­
tionable. It is interesting, a lthough  difficult, to  com pare 
our results w ith the data  of som e w ell-know n reports in 
th e  literature. Since m any infectious episodes in extrem ely 
granulocytopenic patients end  in death , it is o f  limited 
value to com pare the average d u ra tion  o f in fection  with 
th e  average dura tion  of granulocytopenia . U n d e r  this 
restriction, and excluding episodes w ith  PA D  an d  strict 
isolation, analysis shows th a t p roven  infection  w as pres­
en t during 53%  of the days o f extrem e granulocytopenia, 
whereas this percentage is 9.3 fo r the days o f  severe 
granulocytopenia. I f  only m ajo r infections are tak en  into 
account, these percentages are  40 in  extrem e a n d  6.3 in  
severe granulocytopenia. R em arkably , Bodey e t  al. (1) 
also reported tha t 5 3 %  of days w ith  less th an  100 granu lo ­
cytes/m m 3 were days w ith proven  infection . A t levels be­
tween 100 and 500 granulocy tes/m m 3, they  fo u n d  35% . 
The latter percentage is p robab ly  rea lly  d iffe ren t from  
our findings. T he divergence m ight be due to  th e  com posi­
tion  of Bodey's pa tien t m ateria l (all patients w ith  acute 
leukaemia) or nursing m ethods. In  th e ir study, Levine e t 
al. (2) considered only days o f severe infection, p robab ly  
com parable to m ajo r infections in o u r s tudy . T hese 
authors found infection in  4 0 %  of the days w ith  levels 
between 100 and 500/m m 3 in a p a tien t group g iven  co n ­
ventional w ard care. T he results in  these two s tud ies  a re  
very similar to ours w ith respect to  extrem ely  n e u tro p e n ic  
episodes. T he possible differences in  th e  severely  n e u tro ­
penic episodes m ight be explained by the co n v en tio n a l 
isolation of our patients in single room s as opposed  to  
conventional ward care. This kind o f  iso lation  m ig h t p r o ­
vide a limited advantage th a t is lost in  the ex trem e ly  
neutropenic episodes, which m ight req u ire  stric t iso la tio n . 
In  many of the infections seen during  our s tu d y  a  c u re  
was not achieved either w ith antibiotics alone o r  a f te r  th e  
addition of supportive granulocyte transfusions. T h is  h ig h  
proportion of failure of the  therapy  and  the a sso c ia te d  
m ortality m ust be considered in th e  ligh t o f th e  s h o r t ­
term  prognosis of the haem atological status. T h e  to t a l  
outcom e of infection in the patien ts classified a s  h a e m a to -
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logically refracto ry  m ay  be partially  attributable to the 
underlying disease, b u t in  addition  the diagnostic and  
therapeutic approach to  the infection m ay be less active. 
This last consideration  is o ften  disregarded in  clinical 
reports on neutropenic  patients. I f  these cases a re  ex­
cluded, the m ortality  due to  infection is much low er. A  
m ore aggressive fo rm  of an tib io tic therapy  does n o t seem  
to improve these results.
Recently, som e contro lled  studies (7, 8) have ind ica ted  a 
beneficial effect o f  therapeu tic  granulocyte transfusions 
during infectious episodes in granulocytopenic patients. 
It is a pity th a t th e  au thors do n o t discuss the resu lts o f 
the granulocyte transfusions in  relation  to the n u m b e r of 
circulating granulocytes p rio r to transfusion. S ince the 
number of granulocytes th a t can  be transfused is re la tively  
small com pared to  th e  am ount required  in bac te ria l in ­
fections (16), it is questionable w hether granulocyte tra n s­
fusions are o f benefit as long as circulating granulocytes 
are present.
Most patients w ith  granulocytopenia need frequen t red  
cell and platelet transfusions. Successful long-term  supple- 
tion with blood com ponents can only be achieved if  the 
development o f an ti-H L A  antibodies is prevented. I t  is 
now possible to  postpone im m unization via w hite b lood  
cell-antigens by th e  use of extrem ely leucocyte-poor red  
cell suspensions (13) and  p la te le t concentrates (14) from  
random blood donors. H ow ever, granulocyte transfusions 
originating from  ran d o m  donors nullify the e ffo rts  to  
avoid antibody developm ent and m ay make tim e-con­
suming and expensive leucocyte and platelet cross-m atch­
ing necessary.
In this study m orta lity  proved  to  be linked to infection, 
and fatal infections linked to episodes of extrem e g ran u ­
locytopenia. A lthough  th e  num ber o f episodes is ra th e r 
small and the p a tien t group  heterogeneous, w e fee l th a t 
the results support ou r views favouring restricted  use  of 
granulocyte transfusions. W e have doubts about th e  effi­
cacy of transfused granulocytes in patients w ith  m ore  
than 100 circulating granulocytes/m m 3, and w e a re  w ell 
aware of the transfusion  problem  due to  im m unization  
with white b lood  cells. T herefo re  we do no t fav o u r the 
use of prophylactic granulocyte  transfusions and  w e are 
now inclined to  adm in ister granulocyte transfusions only 
to patients w ith  extreme granulocytopenia (less than  
100/mm3) w ho have a  p roven  m ajor infection and  do  no t 
respond prom ptly  to  appropria te  antibiotic therapy.
Only a sm all num ber o f patients in  the present series w ere 
treated in  strict iso lation  and received PA D . W h ethe r 
fewer infections w ere  acquired  during extrem e g ranu lo ­
cytopenia under these conditions cannot be concluded  
from this series. H ow ever, fu rth er investigations have 
shown the benefit o f this fo rm  of treatm ent (17 ,18).
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